121 filings
Page 5 of 7
425
7tlcylrumr
15 Mar 10
Business combination disclosure
12:00am
8-K
soyk8 a29gcaveha846i
15 Mar 10
Myriad Pharmaceuticals, Inc. Sets Date for Special Stockholder Meeting
12:00am
424B3
4a5g1q
12 Mar 10
Prospectus supplement
12:00am
EFFECT
74tzmtnxi
12 Mar 10
Notice of effectiveness
12:00am
425
tf6bii9z0qbe1bp
10 Mar 10
Business combination disclosure
12:00am
CORRESP
zye7106i7p8gbic9wxu
10 Mar 10
Correspondence with SEC
12:00am
8-K
18ut1s6jf28 bm
10 Mar 10
Entry into a Material Definitive Agreement
12:00am
S-4/A
asl4ws8y aasr
10 Mar 10
Registration of securities issued in business combination transactions (amended)
12:00am
UPLOAD
kgg1e9eh
23 Feb 10
Letter from SEC
12:00am
425
rfma6ybluzh5utq3
16 Feb 10
Business combination disclosure
12:00am
8-K
75p bwh51nfxa
16 Feb 10
Myriad Pharmaceuticals Reports Second Quarter FY’ 2010 Financial Results
12:00am
S-4
xv6n hpubqs3c3b
12 Feb 10
Registration of securities issued in business combination transactions
12:00am
8-K
tq43zbowt645
4 Feb 10
Departure of Directors or Certain Officers
12:00am
425
tmt9ei
3 Feb 10
Business combination disclosure
12:00am
8-K
2the1vw4oze7o45
3 Feb 10
Myriad Pharmaceuticals to Present at BIO CEO & Investor Conference on February 8th
12:00am
425
k9ygkc5
2 Feb 10
Business combination disclosure
12:00am
8-K
ttuogcrjwu5z 5ys
2 Feb 10
Other Events
12:00am
425
j56sd9cgi6
25 Jan 10
Business combination disclosure
12:00am
8-K
jgetppiczl4y9d y53t
14 Jan 10
Other Events
12:00am